# onlinesermorelin

> $ man sermorelin — a terminal-style reading room for the GHRH(1-29) record, from the 1990 NDA to the 2025 503A interim policy.

## Pages

- [onlinesermorelin — sermorelin(7) — synthetic 29-residue GHRH analog](/index.md): Manpage-style reference on sermorelin (GHRH 1-29 NH2): mechanism, half-life, FDA history, current US compounding status. Independent editorial summaries of the published record.
- [Sermorelin reported effects and safety: what the record shows](/effects.md): Sermorelin effects and safety read from the GHRH(1-29) record: measured trial outcomes, what research-use communities report (anecdotal), and the cautions that apply. No doses.
- [sermorelin — research record: mechanism, pediatric trials, aging studies, synergy](/research.md): The published research literature on sermorelin (GHRH 1-29 NH2): receptor mechanism, pulsatile GH release, FDA-approval-supporting pediatric trials, aging-population studies, GHRH+GHRP synergy, and the 2024 WADA detection methods.
- [sermorelin — dose ranges in the published trial record](/dosage.md): Dose ranges documented in the FDA-approved pediatric regimen, the adult diagnostic provocation, the Khorram aging study, and the Vittone elderly-men pharmacodynamic study. Research and historical-clinical context only.
- [sermorelin — frequently asked questions](/faq.md): Common questions about sermorelin: what it is, how it works, why the original FDA-approved product was withdrawn, current US compounding status, half-life, and the difference between sermorelin and other GHRH analogs.
- [sermorelin — references](/references.md): Complete numbered citation list with DOIs and PubMed/PMC URLs for every source cited across the onlinesermorelin reading room.
- [about — onlinesermorelin editorial standards](/about.md): onlinesermorelin is an independent editorial project that publishes summaries of the peer-reviewed and regulatory research literature on sermorelin. Not a clinic. Not a pharmacy. Not a vendor.
- [contact — onlinesermorelin](/contact.md): How to reach onlinesermorelin with corrections, source submissions, takedown requests, or research-source recommendations. Not for medical advice or prescription requests.